Skip to Main Content

Paper Details

Longitudinal nucleocapsid antibody testing reveals undocumented SARS-CoV-2 infections in patients with lung cancer.
Cancer Cell
0
2023
LC, Patients, SARS-, SARS-CoV-, SARS-CoV-2, anti-nucleocapsid antibodies, lung cancer, nucleocapsid antibody, patients
Author NameAffiliation
John D MinnaHamon Center for Therapeutic Oncology Research
Rafi AhmedEmory University
  • 1 - 2

Datasets

Release 1.2